City
Epaper

Amanta Healthcare Limited IPO Opens on September 01, 2025

By ANI | Updated: August 25, 2025 15:15 IST

PNNMumbai (Maharashtra) [India], August 25: Amanta Healthcare Limited, a pharmaceutical company engaged in development, manufacturing, and marketing of ...

Open in App

PNN

Mumbai (Maharashtra) [India], August 25: Amanta Healthcare Limited, a pharmaceutical company engaged in development, manufacturing, and marketing of sterile liquid products, including both large and small volume parenterals (LVPs and SVPs), proposes to open its Initial Public Offering on September 01, 2025, aiming to raise ₹ 12,600.00 Lakhs (at upper price band) with shares to be listed on the NSE and BSE Platform.

The issue size is up to 1,00,00,000 equity shares with a face value of ₹ 10 each with a price band of ₹ 120 - ₹ 126 Per Equity Share.

Equity Share Allocation

- Qualified Institutional Buyer - Not more than 50,00,000 Equity Shares

- Non-Institutional Investors - Not less than 15,00,000 Equity Shares

- Individual Investors - Not less than 35,00,000 Equity Shares

The net proceeds from the IPO will be utilized for funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat, funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat, and general corporate purposes. The anchor portion will open on Friday, August 29, 2025 and issue will close on Wednesday, September 03, 2025.

The Book Running Lead Manager to the Issue is Beeline Capital Advisors Private Limited, and the Registrar is MUFG Intime India Private Limited (Formerly Known as Link Intime India Private Limited).

Mr. Bhavesh Patel, Chairman and Managing Director of Amanta Healthcare Limited expressed, "Our company has grown by developing and supplying a wide range of sterile liquid products across therapeutic segments and medical devices. We have established a presence across domestic and international markets. This IPO marks a step forward in our growth journey, allowing us to expand our manufacturing capabilities with new SteriPort and SVP lines at our Hariyala facility, which will strengthen our capacity and support us for Future plans."

(ADVERTORIAL DISCLAIMER: The above press release has been provided by PNN.will not be responsible in any way for the content of the same)

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

International"Milestone achievement to build upon new avenues of partnership": Indian Ambassador to US Vinay Mohan Kwatra on ISRO's LVM3-M6 launch

InternationalBangladeshi journalist Muktadir Rashid calls for "peaceful" relations between New Delhi-Dhaka

International'Awami League not patronising Hadi's killer': Bangladesh Chhatra League General Secy Sheikh Enan

EntertainmentCeline Dion dresses up as ‘Grinch’ and sings ‘All by Myself’ on Christmas

InternationalUncovered million more documents potentially related to Jeffrey Epstein: US Department of Justice

Business Realted Stories

BusinessMP: CM Yadav, Scindia review preparations for Gwalior’s event

BusinessThanks Rahul Gandhi for recognising ‘Make in India’ success: Ashwini Vaishnaw

BusinessVaishnaw thanks Rahul Gandhi for "acknowledging success" of 'Make in India' after Congress leader lauds Karnataka's ecosystem for Foxconn unit

BusinessNasscom flags concerns over new US rules for H-1B visas

BusinessCarrying over 1 million customers every 3 days, fully prepared for holiday season: IndiGo Airlines